Updated : 2 weeks, 3 days ago IST
New Delhi [India], Oct 5 (ANI): The growth and profitability of Indian pharmaceutical companies in current financial year will be constrained by regulatory interventions like price controls in domestic market and compulsory genericisation in overseas market, according to ICRA Ratings.
Updated : 1 month, 3 weeks ago IST
Bengaluru (Karnataka) [India], Aug 27 (ANI): Strides Pharma Science Ltd said on Tuesday that its step-down subsidiary Strides Pharma Inc has acquired a manufacturing facility in Florida from Micelle BioPharma Inc.
Updated : 2 months, 1 week ago IST
New Delhi [India] August 14 (ANI/NewsVoir): Morepen Laboratories Ltd has reported a 256 per cent rise in its net profit (standalone) at Rs 8.41 crore in the first quarter (Q1) of FY 2019-20 as against Rs 2.36 crore net profit registered in the corresponding quarter of the previous fiscal.
Updated : 3 months, 1 week ago IST
Mumbai (Maharashtra) [India], July 15 (ANI): Pharma company Indoco Remedies said on Monday it has received a warning letter from the United States Food and Drug Administration (USFDA) for its oral dosages plant in Goa as a result of the inspection carried out in January.
Updated : 4 months, 1 week ago IST
Pune (Maharashtra) [India] June 11 (ANI/BusinessWire India): Mumbai based Centaur Pharmaceuticals' finished dosage facility in Pune was audited by the USFDA in May 2019 and the audit was concluded with NIL 483 observations.
Updated : 7 months, 2 weeks ago IST
Noida (Uttar Pradesh) [India], Mar 8 (ANI): Jubilant Life Sciences said on Friday that the US Food and Drug Administration (USFDA) has issued a warning letter after conducting an inspection at its manufacturing facility in Roorkee, Uttarakhand.
Updated : 7 months, 3 weeks ago IST
New Delhi [India], Feb 26 (ANI): Aavis Pharmaceuticals, part of Espee Group, located in Hoschton, GA, completed an inspection by the US Food and Drug Administration at the company’s primary manufacturing facility with Zero 483 observations. With successful inspection of its formulat
Updated : 1 year, 2 months ago IST
New Delhi [India], July 30 (NewsVoir): Morepen Laboratories Ltd. has received US FDA (United States Food and Drug Administration) approvals for both its bulk drugs manufacturing facilities situated in Himachal Pradesh.
Updated : 1 year, 9 months ago IST
New Delhi [India], Jan 22 (ANI-NewsVoir): Morepen Laboratories Ltd has reported yet another growth-filled quarter by registering 107 per cent rise in its net profit in Q3 of FY 2017-18 at Rs. 9.67 crore, despite a marginal rise in its net sales revenue at Rs. 139.87 crore, compared to the co
Updated : 1 year, 10 months ago IST
New Delhi [India], Dec 20 (ANI-NewsVoir): The United States Food and Drug Administration (USFDA) has cleared Montelukast Sodium, a bulk drug / API manufactured by Morepen Laboratories Ltd., for sale in the US market. This gives Morepen an entry into the Rs. 2000 crore (Approx. $ 300 million)
Updated : 3 years, 1 month ago IST
New Delhi, Aug 24 (ANI): Strides Shasun in a BSE filing today announced receiving an approval from the US health regulator for Ranitidine tablets used for treating intestinal and stomach ulcers and gastroesophageal reflux disease.